Clearsynth Labs Limited - Due diligence report

A 360° intelligence report on Clearsynth: trust score, financial health, credit view, compliance, directors, growth and distress signals - g…

2010-03-30 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
View plans Plan
CL Clearsynth Labs Limited
View plans Plan
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Clearsynth — 360° Intelligence Report

Generated from MCA filings & public records
87/100
Trust Score
Low Risk

Clearsynth is assessed as Low Risk with a Trust Score of 87/100. Clearsynth is an active public limited indian non-government company incorporated in 2010, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 14 Jul 2026 from the latest processed filings. Clearsynth Labs Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
87/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
74/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
90/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 6 open (113.59 cr) · 8 satisfied (21.85 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others10 48.0 cr
Axis Bank Limited2 48.0 cr
Hdfc Bank Limited1 48.0 cr
Tata Capital Financial Services Limited1 48.0 cr
Compliance Score: 74/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Litigation present in 2 court forum(s).
  • 3 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
VISHWANATHAM AMBATI 01234567 Director 01/04/2018 6 yrs Approved
SUMAN VIJAY AMBATI 01234567 Director 01/04/2018 6 yrs Approved
VIJAY KUMAR AMBATI 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
7 allotment(s) · 4 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
2469483 Ontario Corporation Subsidiary Company 74.00%
Clearsynth Canada Inc Subsidiary Company 74.00%
Amrete Healthcare (india) Private Limited Subsidiary Company 74.00%

Key managerial personnel: SUMAN VIJAY AMBATI (Whole-time director) · VIJAY KUMAR AMBATI (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 90 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Asset base grew 0.86 - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 16+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 61% in a year.
6 open charge(s) registered - assets are encumbered.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence80/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment72/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 6 open charge(s) of 113.59 cr already registered.
  • Compliance record supports lending.
Investor view91/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
31 Dec 2024
Last AGM held
Annual general meeting
13 Sep 2024
Charge satisfied
Others
27 Aug 2024
Charge created
Others - 48.51 cr
31 Mar 2024
Latest balance sheet
Filed with ROC
14 Mar 2024
Charge created
Hdfc Bank Limited - 1.74 cr
28 Feb 2024
Charge created
Axis Bank Limited - 44.40 Lakh
30 Nov 2022
Charge created
Tata Capital Financial Services Limited - 38.89 Lakh
13 May 2022
Charge satisfied
Others
31 Mar 2022
Share transfer (FY 2022)
67934.00000000 shares to VIJAY KUMAR AMBATI
Share transfer (FY 2022)
22000.00000000 shares to TULIP DIAGNOSTICS PRIVATE LIMITED
28 Mar 2022
Charge created
Others - 48.51 cr
14 Mar 2022
Charge satisfied
Others
22 Feb 2022
Securities allotted
160381 Equity Shares - 32.89 cr raised
22 Feb 2021
Director ceased
ANEISH KUMARAN KUMAR
30 Sep 2020
Securities allotted
67934 Equity Shares - 3.00 cr raised
10

Key Observations

Auto-generated from the data above
Revenue grew 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Debt-to-equity stands at 24% - manageable leverage.
Net worth is positive.
3 active director(s) / partner(s); board looks stable and experienced.
3 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 7 security allotment(s) - amounts available in the full report.
10 overseas direct investment(s) (ODI) on record - international footprint.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Civentichem (India) Private Limited U24231TG2001PTC036778 Hyderabad, Telangana, India
Buli Chemicals India U24297MH2018FTC348198 Thane, Maharashtra, India
Koel Colours Pvt Ltd U24220MH1992PTC069373 Mumbai, Maharashtra, India
Elvi Bardahl India Private Limited U52342DL2016PTC292619 New Delhi, Delhi, India
G.G. Organics Private Limited U24297TN2006PTC136231 Chennai, Tamil Nadu, India
Kerala State Drugs And Pharmaceuticals Ltd U24231KL1971SGC002389 Alappuzha, Kerala, India
Chemex Oil Pvt Ltd U15141WB2006PTC107359 Kolkata, West Bengal, India
Biosystems U29297TN2003PTC051492 Sriperumbdur, Tamil Nadu, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Clearsynth before audits and certifications: compliance score 74/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Clearsynth: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Clearsynth - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 87/100, distress signals and MSME payment-delay disclosures - know whether Clearsynth pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Clearsynth - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Clearsynth an active company?

Clearsynth has MCA status “Active” with a compliance score of 74/100 (Moderate).

Is Clearsynth financially healthy?

Clearsynth has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Clearsynth?

Its overall Trust Score is 87/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Clearsynth?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Clearsynth have loans or charges against its assets?

6 open charge(s) are registered against its assets, and 8 earlier charge(s) stand satisfied.

Is Clearsynth up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 74/100 (Moderate).

Is it risky to lend to Clearsynth?

Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.